These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 15247089)

  • 1. Cirrhosis progression as a model of accelerated senescence: affecting the biological aging clock by a breakthrough biophysical methodology.
    Marineo G; Marotta F; Sisti G
    Ann N Y Acad Sci; 2004 Jun; 1019():572-6. PubMed ID: 15247089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysics and clinical practice for regenerative processes in cirrhosis of the liver/of liver cirrhosis assisted by Delta-S Entropy Variation Systems.
    Marineo G; Fesce E
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):365-70. PubMed ID: 17108866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
    Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
    Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysics of aging and therapeutic interventions by entropy-variation systems.
    Marineo G; Marotta F
    Biogerontology; 2005; 6(1):77-9. PubMed ID: 15834666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
    Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
    Carrión JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X
    Liver Transpl; 2006 Dec; 12(12):1791-8. PubMed ID: 16823833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
    Bolondi L; Piscaglia F; Gatta A; Salerno F; Bernardi M; Ascione A; Ferraù O; Sacerdoti D; Visentin S; Trevisani F; Mazzanti R; Donati G; Arena U; Gentilini P;
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1395-402. PubMed ID: 16931172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
    Chang PE; Miquel R; Blanco JL; Laguno M; Bruguera M; Abraldes JG; Bosch J; Garcia-Pagan JC
    Am J Gastroenterol; 2009 Jul; 104(7):1707-14. PubMed ID: 19471257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
    Fontana RJ; Sanyal AJ; Mehta S; Doherty MC; Neuschwander-Tetri BA; Everson GT; Kahn JA; Malet PF; Sheikh MY; Chung RT; Ghany MG; Gretch DR;
    Am J Gastroenterol; 2006 May; 101(5):983-92. PubMed ID: 16573786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.
    Pozzi M; Grassi G; Ratti L; Favini G; Dell'Oro R; Redaelli E; Calchera I; Boari G; Mancia G
    Am J Gastroenterol; 2005 May; 100(5):1110-6. PubMed ID: 15842586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic portal hypertension: a case report.
    Ziarkiewicz-Wróblewska B; Górnicka B; Wróblewski T; Małkowski PM; Zurakowski J; Krawczyk M; Wasiutyński A
    Med Sci Monit; 2004 Nov; 10(11):CS69-72. PubMed ID: 15507857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triplex operation for portal hypertension with esophageal variceal bleeding: report of 140 cases.
    Feng LS; Li K; Peng QP; Ma XX; Zhao YF; Xu PQ; Chen XP
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):534-7. PubMed ID: 15567740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression of gastric varices after iatrogenic injury to a gastrorenal shunt.
    Yamagami T; Iida S; Kato T; Hirota T; Nishimura T
    Australas Radiol; 2006 Feb; 50(1):75-8. PubMed ID: 16499735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.